Lupin has received tentative approval from the US Food and Drug Administration (FDA) for its abbreviated new drug application (ANDA), Drospirenone Tablets in 4 mg strength, the Mumbai-based drug maker said in a statement.from Healthcare/Biotech-Industry-Economic Times https://ift.tt/6SBohTs
via IFTTT
0 comments:
Post a Comment